Tardive Dyskinesia Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 68 pages | ID: T256237E98A4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Tardive Dyskinesia Treatment in Global, including the following market information:

Global Tardive Dyskinesia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tardive Dyskinesia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medical Treatement Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tardive Dyskinesia Treatment include Teva Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc, Sun Pharmaceutical Industries Ltd, SteriMax Inc., Adamas Pharmaceuticals, Inc, Sanis and AbbVie Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tardive Dyskinesia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tardive Dyskinesia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tardive Dyskinesia Treatment Market Segment Percentages, by Type, 2021 (%)

• Medical Treatement
• Self Care

Global Tardive Dyskinesia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tardive Dyskinesia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Tardive Dyskinesia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tardive Dyskinesia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tardive Dyskinesia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tardive Dyskinesia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceutical Industries Ltd
• Neurocrine Biosciences, Inc
• Sun Pharmaceutical Industries Ltd
• SteriMax Inc.
• Adamas Pharmaceuticals, Inc
• Sanis
• AbbVie Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tardive Dyskinesia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tardive Dyskinesia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TARDIVE DYSKINESIA TREATMENT OVERALL MARKET SIZE

2.1 Global Tardive Dyskinesia Treatment Market Size: 2021 VS 2028
2.2 Global Tardive Dyskinesia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tardive Dyskinesia Treatment Players in Global Market
3.2 Top Global Tardive Dyskinesia Treatment Companies Ranked by Revenue
3.3 Global Tardive Dyskinesia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tardive Dyskinesia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tardive Dyskinesia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tardive Dyskinesia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Tardive Dyskinesia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tardive Dyskinesia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tardive Dyskinesia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medical Treatement
  4.1.3 Self Care
4.2 By Type - Global Tardive Dyskinesia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Tardive Dyskinesia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Tardive Dyskinesia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tardive Dyskinesia Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Tardive Dyskinesia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Tardive Dyskinesia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Tardive Dyskinesia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tardive Dyskinesia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Tardive Dyskinesia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Tardive Dyskinesia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Tardive Dyskinesia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tardive Dyskinesia Treatment Revenue, 2017-2028
  6.3.2 US Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.3.3 Canada Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.3.4 Mexico Tardive Dyskinesia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tardive Dyskinesia Treatment Revenue, 2017-2028
  6.4.2 Germany Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.3 France Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.4 U.K. Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.5 Italy Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.6 Russia Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.4.8 Benelux Tardive Dyskinesia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tardive Dyskinesia Treatment Revenue, 2017-2028
  6.5.2 China Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.5.3 Japan Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.5.4 South Korea Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.5.6 India Tardive Dyskinesia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tardive Dyskinesia Treatment Revenue, 2017-2028
  6.6.2 Brazil Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.6.3 Argentina Tardive Dyskinesia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tardive Dyskinesia Treatment Revenue, 2017-2028
  6.7.2 Turkey Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.7.3 Israel Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Tardive Dyskinesia Treatment Market Size, 2017-2028
  6.7.5 UAE Tardive Dyskinesia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva Pharmaceutical Industries Ltd
  7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
  7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  7.1.3 Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Major Product Offerings
  7.1.4 Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 Neurocrine Biosciences, Inc
  7.2.1 Neurocrine Biosciences, Inc Corporate Summary
  7.2.2 Neurocrine Biosciences, Inc Business Overview
  7.2.3 Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Major Product Offerings
  7.2.4 Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Neurocrine Biosciences, Inc Key News
7.3 Sun Pharmaceutical Industries Ltd
  7.3.1 Sun Pharmaceutical Industries Ltd Corporate Summary
  7.3.2 Sun Pharmaceutical Industries Ltd Business Overview
  7.3.3 Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Major Product Offerings
  7.3.4 Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sun Pharmaceutical Industries Ltd Key News
7.4 SteriMax Inc.
  7.4.1 SteriMax Inc. Corporate Summary
  7.4.2 SteriMax Inc. Business Overview
  7.4.3 SteriMax Inc. Tardive Dyskinesia Treatment Major Product Offerings
  7.4.4 SteriMax Inc. Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.4.5 SteriMax Inc. Key News
7.5 Adamas Pharmaceuticals, Inc
  7.5.1 Adamas Pharmaceuticals, Inc Corporate Summary
  7.5.2 Adamas Pharmaceuticals, Inc Business Overview
  7.5.3 Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Major Product Offerings
  7.5.4 Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Adamas Pharmaceuticals, Inc Key News
7.6 Sanis
  7.6.1 Sanis Corporate Summary
  7.6.2 Sanis Business Overview
  7.6.3 Sanis Tardive Dyskinesia Treatment Major Product Offerings
  7.6.4 Sanis Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanis Key News
7.7 AbbVie Inc.
  7.7.1 AbbVie Inc. Corporate Summary
  7.7.2 AbbVie Inc. Business Overview
  7.7.3 AbbVie Inc. Tardive Dyskinesia Treatment Major Product Offerings
  7.7.4 AbbVie Inc. Tardive Dyskinesia Treatment Revenue in Global Market (2017-2022)
  7.7.5 AbbVie Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tardive Dyskinesia Treatment Market Opportunities & Trends in Global Market
Table 2. Tardive Dyskinesia Treatment Market Drivers in Global Market
Table 3. Tardive Dyskinesia Treatment Market Restraints in Global Market
Table 4. Key Players of Tardive Dyskinesia Treatment in Global Market
Table 5. Top Tardive Dyskinesia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tardive Dyskinesia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tardive Dyskinesia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tardive Dyskinesia Treatment Product Type
Table 9. List of Global Tier 1 Tardive Dyskinesia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tardive Dyskinesia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tardive Dyskinesia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tardive Dyskinesia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tardive Dyskinesia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tardive Dyskinesia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tardive Dyskinesia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tardive Dyskinesia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 31. Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Product Offerings
Table 32. Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Neurocrine Biosciences, Inc Corporate Summary
Table 34. Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Product Offerings
Table 35. Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 37. Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Product Offerings
Table 38. Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. SteriMax Inc. Corporate Summary
Table 40. SteriMax Inc. Tardive Dyskinesia Treatment Product Offerings
Table 41. SteriMax Inc. Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Adamas Pharmaceuticals, Inc Corporate Summary
Table 43. Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Product Offerings
Table 44. Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanis Corporate Summary
Table 46. Sanis Tardive Dyskinesia Treatment Product Offerings
Table 47. Sanis Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Inc. Corporate Summary
Table 49. AbbVie Inc. Tardive Dyskinesia Treatment Product Offerings
Table 50. AbbVie Inc. Tardive Dyskinesia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tardive Dyskinesia Treatment Segment by Type in 2021
Figure 2. Tardive Dyskinesia Treatment Segment by Application in 2021
Figure 3. Global Tardive Dyskinesia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tardive Dyskinesia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tardive Dyskinesia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tardive Dyskinesia Treatment Revenue in 2021
Figure 8. By Type - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 12. US Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 24. China Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tardive Dyskinesia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tardive Dyskinesia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. SteriMax Inc. Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanis Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Inc. Tardive Dyskinesia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)